Clinical Trials in Pittsburgh

Showing 2341-2360 of 10,050 trials

Locating Biomarkers in OCD Through Behavioral Tasks

NCT03313622

Subjects that have a diagnosis of OCD will participate in a clinical interview and cognitive tasks, during which they will be exposed to their individual OC stressors or will be asked to make decisions related to information value and quantity while measuring neural activity and filming facial reactions. This will assist investigators to look for biomarkers of that change. This study offers a unique opportunity to develop biomarkers for key domains of OCD, and other neuropsychiatric disorders, that are grounded in brain neurocircuitry at the individual-patient level. Subjects will participate in a clinical interview (Day 1), and then tasks+EEG (Day 2). Day 1 will be 4 hours or less, and Day 2 will be 2.5 hours or less.

OCDObsessive-Compulsive Disorder

Baylor College of Medicine20 participantsStarted Mar 2026

Pittsburgh, Pennsylvania, United States • Providence, Rhode Island, United States • Houston, Texas, United States

RECRUITING< 1 mile

Valved Graft PMCF Study

NCT04754217

Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.

Aortic Valve DiseaseAscending Aorta AbnormalityAortic Dissection

Abbott Medical Devices260 participantsStarted Jul 2021

Birmingham, Alabama, United States • Ann Arbor, Michigan, United States • Asheville, North Carolina, United States +22 more locations

Locating Biomarkers in OCD Through Behavioral Tasks

Valved Graft PMCF Study

Find Trials by Condition in Pittsburgh

Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative (HER2-) Breast Cancer Susceptibility Gene Mutation (BRCAmut) or Triple-Negative Breast Cancer (TNBC) With Molecular Disease

A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP

Analysis of Surgery in Patients Presenting With Stage IV Breast Cancer

Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

ALTO-100 in Bipolar Disorder With Depression (BD-D)

A Study of RSLV-132 in Females With Sjögren's Disease

An Efficacy and Safety Study of Cofetuzumab Pelidotin in Participants With PTK7-Expressing, Recurrent Non-Small Cell Lung Cancer

A Study of Atezolizumab Plus Cobimetinib and Vemurafenib Versus Placebo Plus Cobimetinib and Vemurafenib in Previously Untreated BRAFv600 Mutation-Positive Patients With Metastatic or Unresectable Locally Advanced Melanoma

Study to Investigate the Efficacy, Safety, and Tolerability of Topical HT-001 for the Treatment of Skin Toxicities Associated With Epidermal Growth Factor Receptor Inhibitors

A Study to Compare Nighttime Aligners to Daytime Aligners

SELF-CERV Pivotal Study: SELF-Collection for CERVical Cancer Screening

A Trial to Evaluate the Efficacy and Safety of Tafasitamab With Bendamustine (BEN) Versus Rituximab (RTX) With BEN in Adult Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)

A Study of mRNA-1018 Pandemic Influenza Candidate Vaccines in Healthy Adults

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis

Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications

9-ING-41 in Pediatric Patients With Refractory Malignancies.

Study to Assess AFM24 in Advanced Solid Cancers

Stereotactic MRI-guided Adaptive Radiation Therapy (SMART) in One Fraction